SAKK 08/15 PROMET
PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after ProstatectomyThe main objective of the trial is to explore the efficacy of SRT plus metformin compared to SRT in the endpoint of time to progression after prostatectomy failure.
|type of project||clinical studies|
|status||ongoing - follow up|
|start of project||2017|
|end of project||2030|
|study design||International multicenter, randomized phase II trial.|
|responsible person||Prof. Dr. Paul Martin Putora|